Utilizing dynamic treatment information for MACE prediction of acute coronary syndrome
Abstract Background Main adverse cardiac events (MACE) are essentially composite endpoints for assessing safety and efficacy of treatment processes of acute coronary syndrome (ACS) patients. Timely prediction of MACE is highly valuable for improving the effects of ACS treatments. Most existing tools...
Main Authors: | Huilong Duan, Zhoujian Sun, Wei Dong, Zhengxing Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Medical Informatics and Decision Making |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12911-018-0730-7 |
Similar Items
-
Contemporary retrospective analysis of acute coronary syndrome. An Egyptian study
by: Hany Tawfeek, et al.
Published: (2016-08-01) -
Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
by: Gaoqiang Xie, et al.
Published: (2017-08-01) -
Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
by: Jason Nogic, et al.
Published: (2023-01-01) -
‘Mace sign’- A definitive sign of trichotillomania?
by: Subrata Malakar, et al.
Published: (2017-10-01) -
ORIGINAL PAPER<br> Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention
by: Leszek Markuszewski, et al.
Published: (2006-03-01)